Agonist-activated, ryanodine-sensitive, IP3-insensitive Ca2+ release channels in longitudinal muscle of intestine

Am J Physiol. 1994 May;266(5 Pt 1):C1421-31. doi: 10.1152/ajpcell.1994.266.5.C1421.

Abstract

We have previously shown that Ca2+ mobilization in longitudinal muscle is not mediated by inositol 1,4,5-trisphosphate (IP3) and depends on an obligatory influx of Ca2+. The present study examined whether Ca2+ influx activates ryanodine-sensitive Ca2+ channels to cause Ca(2+)-induced Ca2+ release. Ryanodine bound with high affinity to longitudinal muscle cells [dissociation constant (Kd) 7.3 +/- 0.3 nM] and microsomes (Kd 7.5 +/- 0.4 nM) and induced concentration-dependent 45Ca2+ efflux [50% effective concentration (EC50) 1.3 +/- 0.5 nM], increase in cytosolic free Ca2+ (EC50 2.0 +/- 0.7 nM), and contraction (EC50 0.9 +/- 0.2 nM) but had no effect in circular muscle cells. Ryanodine binding and ryanodine-induced Ca2+ release were enhanced by caffeine and inhibited by dantrolene and ruthenium red but were not affected by IP3 or heparin. Changes in Ca2+ concentration (50-500 nM) caused Ca2+ release from permeabilized longitudinal but not circular muscle cells loaded with 45Ca2+. The contractile agonist cholecystokinin-8 elicited 45Ca2+ efflux in both circular and longitudinal muscle cells; efflux in longitudinal muscle cells was abolished by Ca2+ channel blockers and by pretreatment of the cells with ryanodine. Pretreatment with thapsigargin abolished agonist-induced 45Ca2+ efflux in both cell types. We conclude that ryanodine-sensitive IP3-insensitive Ca2+ release channels with properties similar to those in cardiac muscle are present in longitudinal but not circular muscle cells of intestine and that agonist-mediated Ca2+ influx activates these channels, leading to Ca(2+)-induced Ca2+ release.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Binding, Competitive
  • Caffeine / pharmacology
  • Calcium / metabolism*
  • Calcium Channels / drug effects
  • Calcium Channels / metabolism*
  • Calcium Channels / physiology*
  • Calcium-Transporting ATPases / antagonists & inhibitors
  • Dantrolene / pharmacology
  • Heparin / pharmacology
  • In Vitro Techniques
  • Inositol 1,4,5-Trisphosphate / metabolism*
  • Inositol 1,4,5-Trisphosphate / pharmacology*
  • Intestinal Mucosa / metabolism
  • Intestines / drug effects
  • Intestines / physiology*
  • Kinetics
  • Microsomes / drug effects
  • Microsomes / metabolism*
  • Muscle Contraction / drug effects
  • Muscle Contraction / physiology*
  • Muscle Proteins / metabolism*
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / metabolism
  • Muscle, Smooth / physiology*
  • Rabbits
  • Ruthenium Red / pharmacology
  • Ryanodine / metabolism*
  • Ryanodine / pharmacology
  • Ryanodine Receptor Calcium Release Channel
  • Terpenes / pharmacology
  • Thapsigargin
  • Time Factors

Substances

  • Calcium Channels
  • Muscle Proteins
  • Ryanodine Receptor Calcium Release Channel
  • Terpenes
  • Ruthenium Red
  • Ryanodine
  • Caffeine
  • Thapsigargin
  • Inositol 1,4,5-Trisphosphate
  • Heparin
  • Calcium-Transporting ATPases
  • Dantrolene
  • Calcium